VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 121 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $60,000 | -17.8% | 10,165 | -62.5% | 0.01% | -16.7% |
| Q4 2021 | $73,000 | +2.8% | 27,100 | 0.0% | 0.01% | +20.0% |
| Q3 2021 | $71,000 | -53.3% | 27,100 | -26.4% | 0.01% | -50.0% |
| Q2 2021 | $152,000 | -63.8% | 36,800 | -58.7% | 0.01% | -66.7% |
| Q1 2021 | $420,000 | +6.1% | 89,158 | +61.2% | 0.03% | +11.1% |
| Q4 2020 | $396,000 | -17.3% | 55,317 | +23.3% | 0.03% | -15.6% |
| Q3 2020 | $479,000 | +7.9% | 44,852 | +27.5% | 0.03% | +6.7% |
| Q2 2020 | $444,000 | +214.9% | 35,166 | +248.9% | 0.03% | +233.3% |
| Q4 2019 | $141,000 | -27.3% | 10,078 | -1.9% | 0.01% | +12.5% |
| Q3 2018 | $194,000 | -91.7% | 10,276 | -91.4% | 0.01% | -91.0% |
| Q2 2018 | $2,335,000 | -16.4% | 119,500 | -19.6% | 0.09% | -5.3% |
| Q1 2018 | $2,792,000 | -3.6% | 148,600 | -14.8% | 0.09% | +11.9% |
| Q4 2017 | $2,895,000 | +122.2% | 174,400 | +175.6% | 0.08% | +95.3% |
| Q3 2017 | $1,303,000 | – | 63,287 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |